Table 1.
Patient | Age (years) | Country of birth | #Parity | Education level attained | Psychiatric diagnosis | Medication |
---|---|---|---|---|---|---|
P1 | 31 | Australia | 1 | Not completed | Bipolar type 1 |
lithium 450 mg lamotrigine 50 mg, quetiapine 50 mg |
P2 | 29 | Australia | 2 | Year 12 | Bipolar type 1 |
lithium 1250 mg quetiapine 200 mg |
P3 | 33 | Australia | 1 | Tertiary | Bipolar type 2 |
lithium 900 mg duloxetine 120 mg escitalopram 20 mg lamotrigine 200 mg quetiapine XR 250 mg |
P4 | 36 | Australia | 1 | Tertiary | Bipolar type 1 | aripiprazole 10 mg |
P5 | 30 | Australia | 2 | Year 12 | Bipolar type 2 |
Fluoxetine 40 mg lamotrigine 400 mg quetiapine 100 mg |
P6 | 41 | Australia | 2 | Tertiary | Bipolar type 1 |
lamotrigine 200 mg escitalopram 10 mg olanzapine 2.5 mg |
P7 | 34 | Australia | 6 | Not completed | Bipolar type 2 |
Lithium 450 mg Olanzapine 5 mg mirtazapine 30 mg |
P8 | 28 | Afghanistan | 1 | Year 12 | Schizophrenia | olanzapine 5 mg |
P9 | 33 | Australia | 3 | Tertiary | Bipolar type 2 | quetiapine XR 300 mg |
P10 | 37 | Australia | 1 | Trade certificate | Bipolar type 1 |
lamotrigine 300 mg sertraline 100 mg |
P11 | 33 | Australia | 2 | Trade certificate | Schizophrenia |
aripiprazole 10 mg olanzapine 10 mg |
P12 | 31 | Ethiopia | 2 | Trade certificate | Schizophrenia | aripiprazole depo 400 mg |
#parity = births completed